시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 오메프라졸 시장 보고서(2025년)
Omeprazole Global Market Report 2025
상품코드 : 1825840
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,707,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,694,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,682,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

오메프라졸 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 7.0%로 32억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 수익성에 영향을 미치는 약가 통제를 위한 정부 개입, 오메프라졸의 가용성 및 가격 책정에 영향을 미치는 의약품 공급망 혼란, 개별화된 치료 접근법, 셀프케어 제품에 대한 소비자의 인식과 선호도 증가, 오메프라졸 수요에 영향을 미치는 질병 패턴 및 유병률 변화 등에 기인합니다. 등에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 유전자 편집 기술 개발, 약리유전체학 발전, 원격의료 도입, 디지털 헬스 기술 통합, 온라인 플랫폼 확대 등을 꼽을 수 있습니다.

향후 5년간 7.0%의 성장률 전망은 지난번 예측보다 0.7% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 스페인과 중국에서 조달되는 양성자 펌프 억제제 원약과 지연 방출 캡슐의 가격을 상승시켜 소화기 의료비를 악화시키고 약국에서 구입할 수 있는 가격을 제한함으로써 미국 환자들에게 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

오메프라졸 시장은 위암 발병률 증가로 인해 성장세를 보이고 있습니다. 위암은 위 점막에서 발생하며, 만성 헬리코박터 파일로리균 감염, 다량의 알코올 섭취, 유전적 요인, 만성 위염, 비만, 지역적 유병률 차이 등의 요인에 기인합니다. 양성자 펌프 억제제인 오메프라졸은 위산 분비를 억제하여 위암 관리에 중요한 역할을 하며, 그 결과 증상을 완화하고 삶의 질을 개선하며 위궤양과 병변의 치유를 돕습니다. 예를 들어, 미국 암학회는 미국 내 2021년 338,090건에서 2023년 348,840건으로 3.18% 증가하여 위장암이 증가할 것으로 보고하여 오메프라졸 시장의 성장 동력을 강조하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Omeprazole, classified as a proton pump inhibitor, is utilized in the treatment of acid reflux, stomach ulcers, and related conditions characterized by excessive stomach acid production. Its mechanism involves the irreversible blockade of the H+/K+ ATPase enzyme system (known as the proton pump) within gastric parietal cells, leading to a reduction in stomach acid secretion.

The primary dosage forms of omeprazole include capsules, powder, and tablets. Capsules are solid formulations wherein the drug is encapsulated within a soluble container typically composed of gelatin. Omeprazole is prescribed for a variety of ailments such as duodenal ulcers, gastric ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis, among others. Its distribution channels encompass hospital pharmacies, retail pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The omeprazole market research report is one of a series of new reports from The Business Research Company that provides omeprazole market statistics, including the omeprazole industry global market size, regional shares, competitors with omeprazole market share, detailed omeprazole market segments, market trends, and opportunities, and any further data you may need to thrive in the omeprazole industry. These omeprazole market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The omeprazole market size has grown strongly in recent years. It will grow from $2.34 billion in 2024 to $2.5 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to reimbursement policies, transition of patients and healthcare providers from H2 blockers to proton pump inhibitors, educational campaigns raising awareness about the benefits of omeprazole therapy, Government spending on healthcare infrastructure and services, and health literacy initiatives.

The omeprazole market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to government interventions to control drug prices affecting profitability, disruptions in the pharmaceutical supply chain affecting omeprazole availability and pricing, personalized treatment approaches, increasing consumer awareness and preference for self-care products and changes in disease patterns and prevalence rates affecting the demand for omeprazole. Major trends in the forecast period include development of gene editing technologies, advancements in pharmacogenomics, adoption of telemedicine, integration of digital health technologies and expansion of online platforms.

The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of proton-pump inhibitor Active Pharmaceutical Ingredient(APIs) and delayed-release capsules sourced from Spain and China, exacerbating gastrointestinal care costs and limiting pharmacy affordability. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The omeprazole market is poised for growth due to the rising incidence of gastric cancers. These cancers originate in the stomach lining and are attributed to factors such as chronic helicobacter pylori infection, heavy alcohol use, genetic factors, chronic gastritis, obesity, and geographical differences in prevalence. Omeprazole, a proton pump inhibitor, plays a crucial role in managing gastric cancers by reducing stomach acid production, which in turn alleviates symptoms, improves quality of life, and aids in healing stomach ulcers or lesions. For example, the American Cancer Society reported a 3.18% increase in gastrointestinal cancers to 348,840 cases in 2023 compared to 338,090 cases in 2021 in the United States, highlighting the driving force behind the omeprazole market's growth.

Key players in the omeprazole market are focusing on developing liquid formulations for enhanced patient convenience and adherence, especially for individuals who have difficulty swallowing pills or capsules. Liquid forms of omeprazole offer benefits such as improved patient compliance, convenience, accurate dosing, faster onset of action, and better medication stability. For instance, Alkaloid AD introduced liquid Omeprazole in February 2024, designed specifically for reflux esophagitis and GERD patients who struggle with tablet ingestion. This innovation, packaged in a dual-chamber format, addresses the needs of patients such as young children, adults with swallowing difficulties, individuals with gastric feeding tubes, and elderly patients, providing a practical treatment solution. The company's international patent and regulatory approvals demonstrate the product's value and accessibility in various markets.

In July 2022, Italfarmaco acquired Lacer to bolster its presence in the Spanish healthcare sector and expand its product range and global reach using Lacer's established brands and manufacturing capabilities. Lacer, a Spanish pharmaceutical company specializing in healthcare products including omeprazole capsules, adds value to Italfarmaco's portfolio and growth strategy.

Major companies operating in the omeprazole market are Pfizer Inc., AstraZeneca plc, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Fresenius Kabi, Macleods Pharmaceuticals Pvt Ltd., Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla, Apotex Inc., Amneal Pharmaceuticals, Lupin Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals, Jubilant Generics Limited, Accord Healthcare, Hetero Healthcare Limited, Zydus Cadila, Ranbaxy Laboratories Limited

North America was the largest region in the omeprazole market in 2024. The regions covered in the omeprazole market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the omeprazole market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The omeprazole market consists of sales of delayed-release capsules, oral disintegrating tablets, and oral suspensions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Omeprazole Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on omeprazole market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for omeprazole ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The omeprazole market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Omeprazole Market Characteristics

3. Omeprazole Market Trends And Strategies

4. Omeprazole Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Omeprazole Growth Analysis And Strategic Analysis Framework

6. Omeprazole Market Segmentation

7. Omeprazole Market Regional And Country Analysis

8. Asia-Pacific Omeprazole Market

9. China Omeprazole Market

10. India Omeprazole Market

11. Japan Omeprazole Market

12. Australia Omeprazole Market

13. Indonesia Omeprazole Market

14. South Korea Omeprazole Market

15. Western Europe Omeprazole Market

16. UK Omeprazole Market

17. Germany Omeprazole Market

18. France Omeprazole Market

19. Italy Omeprazole Market

20. Spain Omeprazole Market

21. Eastern Europe Omeprazole Market

22. Russia Omeprazole Market

23. North America Omeprazole Market

24. USA Omeprazole Market

25. Canada Omeprazole Market

26. South America Omeprazole Market

27. Brazil Omeprazole Market

28. Middle East Omeprazole Market

29. Africa Omeprazole Market

30. Omeprazole Market Competitive Landscape And Company Profiles

31. Omeprazole Market Other Major And Innovative Companies

32. Global Omeprazole Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Omeprazole Market

34. Recent Developments In The Omeprazole Market

35. Omeprazole Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기